Medical devices, healthcare technology and the business of care
510(k) clearance · K253713

Arthrex Variable Angle (VA) Proximal Tibia Plating System

ARTHREX, INC. · Decision date Jan 21, 2026

FDA DECISIONK253713

What did the FDA decide?

FDA records K253713 as a 510(k) premarket notification, with a decision dated Jan 21, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Orthopedic
Decision date
Jan 21, 2026

FDA source record

Regulatory record facts

Identifier
K253713
Regulatory pathway
510(k) premarket notification
Applicant
ARTHREX, INC.
Product code
HRS
Decision code
SESE
Decision date
Jan 21, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Plate, Fixation, Bone.

Applicant
Arthrex, Inc.
Product code
HRS
FDA device class
2

FDA decision timeline

  1. K253713 received

    Application receipt date recorded by FDA.

  2. K253713 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code HRS

Product / regulatory recordCompanyPathwayDecision dateSource
Hero Orthopedics, LLC510(k) clearanceNov 2, 2026FDA
ARTHREX, INC.510(k) clearanceOct 29, 2026FDA
Skeletal Dynamics, Inc.510(k) clearanceOct 26, 2026FDA
GLOBUS MEDICAL, INC.510(k) clearanceOct 23, 2026FDA
Pace Surgical510(k) clearanceOct 23, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Arthrex, Inc.

Headquarters
Not reported
Brand website
arthrex.com
FDA applicant address
Naples, FL

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records